Gene · 6950
Papers1,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From protection to progression: How CCT/TRiC shapes therapy-induced senescence in glioblastoma multiforme. | Biochim Biophys Acta Mol Basis Dis | 2027 | 42624300 | PubTator, text mining | PubMed |
| Differential Modulation of the DR5-JNK-PD-L1 Signaling Axis by TRiC/CCT Subunits CCT7 and CCT2 Shapes Tumor Immune Evasion in Lung Adenocarcinoma. | Cells | 2026 | 42738906 | PubTator, text mining | PubMed |
| CCT3 Enhances Lung Adenocarcinoma Progression by Promoting p53 Ubiquitination and Degradation. | Medicina (Kaunas) | 2026 | 42654382 | PubTator, text mining | PubMed |
| CCT2 enhances c-Myc stabilization to drive tumor progression and chemoresistance in head and neck squamous cell carcinoma. | Genes Dis | 2026 | 42620170 | PubTator, text mining | PubMed |
| PPP2R2C promotes aerobic glycolysis and mediates pemetrexed resistance in lung adenocarcinomas by upregulating TCP1-dependent protein folding of glycolytic enzymes. | Respir Res | 2026 | 42464257 | PubTator, text mining | PubMed |
| Serum and adipose tissue-derived extracellular vesicles as biomarker reservoirs in oesophageal adenocarcinoma. | Sci Rep | 2026 | 42350602 | PubTator, text mining | PubMed |
| Hybrid Feature Selection-Based Machine Learning and Deep Learning Framework for Biomarker Prediction From RNA-seq Data During Dengue Fever to Severe Dengue Progression. | Evol Bioinform Online | 2026 | 42137783 | PubTator, text mining | PubMed |
| Identification of RPL4 as a biomarker associated with disulfidptosis and arachidonic acid metabolism in breast cancer. | Discov Oncol | 2026 | 42096008 | PubTator, text mining | PubMed |
| Chaperonin in health and disease. | Mol Biomed | 2026 | 41920440 | PubTator, text mining | PubMed |
| Knockdown of CCT2 inhibits the malignant progression of hepatocellular carcinoma cells by impairing STAT3 activation. | Oncol Rep | 2026 | 41789667 | PubTator, text mining | PubMed |
| Decreased Glucose Metabolism and Declined Chaperones Are Unique Features Required for the Survival of Senescent Fibroblasts and Pyruvate Dehydrogenase Is a Potent Senolytic Target. | Aging Cell | 2026 | 41786630 | PubTator, text mining | PubMed |
| Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches. | Mol Biomed | 2026 | 41772328 | PubTator, text mining | PubMed |
| Dysregulation of the DNA damage response by phosphorothioate antisense oligonucleotides. | Nat Commun | 2026 | 41760661 | PubTator, text mining | PubMed |
| Lipid Metabolism Reprogramming in Diffuse Large B-Cell Lymphoma (DLBCL): Mechanisms and Treatment Strategies. | Cancers (Basel) | 2026 | 41749954 | PubTator, text mining | PubMed |
| Extracellular vesicles and their role in Lupus Nephritis: A scoping review. | J Transl Autoimmun | 2026 | 41732236 | PubTator, text mining | PubMed |
| CCT5 as a candidate biomarker in bladder cancer: functional validation and mechanistic clues. | Am J Cancer Res | 2026 | 41657783 | PubTator, text mining | PubMed |
| Characterization of Usher Syndrome Type 2-Associated Proteins in the Retina via Affinity Purification-Mass Spectrometry. | Mol Cell Proteomics | 2026 | 41654259 | PubTator, text mining | PubMed |
| Domain-selective folding of the tandem β-propeller protein Coronin 7 (Coro7) by the chaperonin CCT/TRiC. | J Biol Chem | 2026 | 41654136 | PubTator, text mining | PubMed |
| Proximity labeling reveals non-catalytic interactions between DPP9 and ubiquitin signaling complexes. | Cell Mol Life Sci | 2026 | 41636814 | PubTator, text mining | PubMed |
| CCT7 predicts poor prognosis and correlates with immune infiltration in colonic adenocarcinoma. | J Mol Histol | 2026 | 41604027 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6950/papers